Objective: The objective of this study was to assess adherence to antidiabetic therapy in type II diabetic patients and factors associated with Lomé. Method: This was a descriptive observational study conducted among diabetics in diabetes care centers from May 1, 2020 to October 1, 2020, for a period of 6 months. Results: A total of 300 patients were questioned. The mean age was 56.61 years (standard deviation = 11.7). The sex ratio was 0.6. All the patients were on drug treatment, 83.4% of whom were on metformin and 37.5% on Glibenclamide. In 58.3% of the cases, the patients were on dual therapy and 96.2% had an abovenormal glycated hemoglobin value. There was a medication adherence problem with poor adherence in 30.7%. Being aged 50 and over (ORC = 1.78, p = 0.048), playing sports (ORR = 1.87, p = 0.046), have reaching a higher level of education (ORR = 5.78, p = 0.005) significantly increased the chances of patients having a good/minimal problem of adherence. Conclusion: Diabetes affects in Togo, more women than men with a predominance of those aged 50 and over. Adherence to therapy remains a challenge.
References
[1]
Jaffiol, C. (2011) The Burden of Diabetes in Africa: A Major Public Health Problem. Bulletin de l’Académie Nationale de Médecine, 195, 1239-1253. https://doi.org/10.1016/S0001-4079(19)31983-1
[2]
Gelaw, B., Mohammed, A., Tegegne, G., Defersha, A., Fromsa, M., Tadesse, E., et al. (2014) Nonadherence and Contributing Factors among Ambulatory Patients with Antidiabetic Medications in Adama Referral Hospital. Journal of Diabetes Research, 2014, Article ID: 617041. https://doi.org/10.1155/2014/617041
[3]
Tiéno, H., Bouda, M., Ouédraogo, D.D., Traoré, R., Ouédraogo, C. and Drabo, Y.J. (2010) Observance to Antidiabetic Treatment in a Developing Country: The Case in Burkina Faso (Sub-Saharan Africa). Médecine des maladies Métaboliques, 4, 207-211. https://doi.org/10.1016/S1957-2557(10)70046-8
[4]
Kalyango, J.N., Owino, E. and Nambuya, A.P. (2008) Non-Adherence to Diabetes Treatment at Mulago Hospital in Uganda: Prevalence and Associated Factors. African Health Science, 8, 67-73.
[5]
Sabaté, E. (2003) Adherence to Long-Term Therapies: Evidence for Action. World Health Organization.
[6]
Organisation mondiale de la santé (OMS) (2016) Rapport mondial sur le diabète. OMS, Génève, 88 p.
[7]
Girerd, X., Hanon, O. and Vaïsse, B. (2018) Utilisation de l’échelle d’observance EvalObs® dans une population de sujets traités pour une hypertension, une dyslipidémie ou un diabète: enquête FLAHS observance 2017. Annales de cardiologie et d’angéologie, 67, 186-190.
[8]
Ntyonga-Pono, M.P. (2015) L’observance du traitement antidiabétique chez les patients diabétiques au Gabon: Données préliminaires. Médecine des Maladies Métaboliques, 9, 198-202. https://doi.org/10.1016/S1957-2557(15)30043-2
[9]
Rwegerera, G.M. (2014) Adherence to Anti-Diabetic Drugs among Patients with Type 2 Diabetes Mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania-A Cross-Sectional Study. The Pan African Medical Journal, 17, 12-18. https://doi.org/10.11604/pamj.2014.17.252.2972
[10]
Kalyango, J., Owino, E. and Nambuya, A. (2008) Non-Adherence to Diabetes Treatment at Mulago Hospital in Uganda: Prevalence and Associated Factors. African Health Sciences, 8, 67-73.
[11]
Wanvoegbe, F.A., Agbodande, K.A., Alassani, A., Aviansou, A., Gninkoun, J., Amoussou-Guenou, D., et al. (2018) Evaluation de l’observance thérapeutique chez les diabétiques au Bénin. Médecine d’Afrique Noire, 65, 355-361.
[12]
Achouri, M.Y., Tounsi, F., Messaoud, M., Senoussaoui, A. and Abdelaziz, A.B. (2021) Prévalence de la mauvaise observance thérapeutique chez les diabétiques de type 2 en Afrique du Nord. Revue systématique et méta-analyse. Tunisie médicale, 99, 932-945.
[13]
Jannoo, Z. and Mamode, K.N. (2019) Medication Adherence and Diabetes Self-Care Activities among Patients with Type 2 Diabetes Mellitus. Value in Health Regional Issues, 18, 30-35. https://doi.org/10.1016/j.vhri.2018.06.003
[14]
Ahmad, N.S., Ramli, A., Islahudin, F. and Paraidathathu, T. (2013) Medication Adherence in Patients with Type 2 Diabetes Mellitus Treated at Primary Health Clinics in Malaysia. Patient Preference and Adherence, 7, 525-530. https://doi.org/10.2147/PPA.S44698
[15]
Guénette, L., Moisan, J., Breton, M.C., Sirois, C. and Grégoire, J.P. (2013) Difficulty Adhering to Antidiabetic Treatment: Factors Associated with Persistence and Compliance. Diabetes & Metabolism, 39, 250-257. https://doi.org/10.1016/j.diabet.2012.12.005
[16]
Simard, P., Presse, N., Roy, L., Dorais, M., White-Guay, B., Räkel, A. and Perreault, S. (2015) Persistence and Adherence to Oral Antidiabetics: A Population-Based Cohort Study. Acta Diabetologica, 52, 547-556. https://doi.org/10.1007/s00592-014-0692-x
[17]
Yazew, K.G., Walle, T.A. and Azagew, A.W. (2019) Prevalence of Anti-Diabetic Medication Adherence and Determinant Factors in Ethiopia: A Systemic Review and Meta-Analysis. International Journal of Africa Nursing Sciences, 11, Article 100167. https://doi.org/10.1016/j.ijans.2019.100167
[18]
Jaam, M., Ibrahim, M.I.M., Kheir, N. and Awaisu, A. (2017) Factors Associated with Medication Adherence among Patients with Diabetes in the Middle East and North Africa Region: A Systematic Mixed Studies Review. Diabetes Research and Clinical Practice, 129, 1-15. https://doi.org/10.1016/j.diabres.2017.04.015
[19]
Curkendall, S.M., Thomas, N., Bell, K.F., Juneau, P.L. and Weiss, A.J. (2013) Predictors of Medication Adherence in Patients with Type 2 Diabetes Mellitus. Current Medical Research and Opinion, 29, 1275-1286. https://doi.org/10.1185/03007995.2013.821056
[20]
Tunceli, K., Zhao, C., Davies, M.J., Brodovicz, K.G., Alexander, C.M., Iglay, K. and Radican, L. (2015) Factors Associated with Adherence to Oral Antihyperglycemic Monotherapy in Patients with Type 2 Diabetes. Patient Preference and Adherence, 9, 191-197. https://doi.org/10.2147/PPA.S71346
